Amplitude Ventures
About Amplitude Ventures
Amplitude Ventures is a full-stack venture capital firm headquartered in Montreal, with offices in Toronto and Calgary. It creates, builds, and grows precision medicine companies at the intersection of biology and AI, investing from ideation to patient care and managing over $500 million.
Portfolio companies include Thryv Therapeutics, Nomic Bio, Prilenia, Congruence Therapeutics, Evommune, Gandeeva Therapeutics, and DCx Biotherapeutics. Recent activity includes Thryv’s Series B, which will fund a Phase 2a heart failure study.
As company builders, the team works alongside founders on strategy, fundraising, and connections to talent and other investors. Pre-Amp supports earlier-stage concepts, and the annual Amplitude Fellowship brings Canadian PhD candidates, postdocs, and MDs together to develop new biotech ideas.
People
- Jean-Francois Pariseau, Co-Founder & Managing Partner